Nu Skin Enterprises, Inc (NYSE:NUS) traded at $7.27 at close of the session on Tuesday, February 18 and made a downward move of -3.84% on its previous day’s price.
Nu Skin Enterprises, Inc has a market cap of $361.48 million and is expected to release its quarterly earnings report in March. With its Forward Dividend at 0.24 and a yield of 3.30%, the company’s investors could be anxious for the NUS stock to gain ahead of the earnings release.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 354.3M, with a low of 352.1M and a high of 356.5M. The median projection represents growth adding up to -15.10% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 1.54B, or -10.90% down from figures reported last year.
On the other hand, looking at the outlook for the NUS stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of Hold.
Looking further, we note the current price level is 7.43% off its SMA20 and 4.62% from its 50-day simple moving average. The RSI (14) is pointing at 58.14 while the volatility over the past week is 10.69% and jumps to 5.85% over the past one month. The beta value is 1.09, while the average true range (ATR) is currently pointing at 0.56. The average price target for the stock over the next 12 months is $11, with the estimates having a low of $11 and a high of $11. These price ends are -51.31% and -51.31% off the current price level respectively, although investors could be excited at the prospect of a -51.31% if the NUS share price touches on the median price of $11.
